231 related articles for article (PubMed ID: 30748020)
1. Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor γ in Mice.
Tong J; Han CJ; Zhang JZ; He WZ; Zhao GJ; Cheng X; Zhang L; Deng KQ; Liu Y; Fan HF; Tian S; Cai J; Huang Z; She ZG; Zhang P; Li H
Hepatology; 2019 Jun; 69(6):2471-2488. PubMed ID: 30748020
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
3. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression.
Li L; Fu J; Liu D; Sun J; Hou Y; Chen C; Shao J; Wang L; Wang X; Zhao R; Wang H; Andersen ME; Zhang Q; Xu Y; Pi J
Redox Biol; 2020 Feb; 30():101412. PubMed ID: 31901728
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease.
Hajri T; Zaiou M; Fungwe TV; Ouguerram K; Besong S
Cells; 2021 May; 10(6):. PubMed ID: 34072832
[TBL] [Abstract][Full Text] [Related]
5. Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways.
Huang Z; Wu LM; Zhang JL; Sabri A; Wang SJ; Qin GJ; Guo CQ; Wen HT; Du BB; Zhang DH; Kong LY; Tian XY; Yao R; Li YP; Liang C; Li PC; Wang Z; Guo JY; Li L; Dong JZ; Zhang YZ
Hepatology; 2019 Oct; 70(4):1099-1118. PubMed ID: 30820969
[TBL] [Abstract][Full Text] [Related]
6. Inflammation is independent of steatosis in a murine model of steatohepatitis.
Wang W; Xu MJ; Cai Y; Zhou Z; Cao H; Mukhopadhyay P; Pacher P; Zheng S; Gonzalez FJ; Gao B
Hepatology; 2017 Jul; 66(1):108-123. PubMed ID: 28220523
[TBL] [Abstract][Full Text] [Related]
7. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
Zheng F; Cai Y
Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
[TBL] [Abstract][Full Text] [Related]
8. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet.
Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
10. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Li X; Wang Z; Klaunig JE
Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
[TBL] [Abstract][Full Text] [Related]
11. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
[TBL] [Abstract][Full Text] [Related]
12. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW
Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255
[TBL] [Abstract][Full Text] [Related]
13. Glial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expression.
Mwangi SM; Peng S; Nezami BG; Thorn N; Farris AB; Jain S; Laroui H; Merlin D; Anania F; Srinivasan S
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G103-16. PubMed ID: 26564715
[TBL] [Abstract][Full Text] [Related]
14. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
15. Glial Cell Line-Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity.
Mwangi SM; Li G; Ye L; Liu Y; Reichardt F; Yeligar SM; Hart CM; Czaja MJ; Srinivasan S
Hepatology; 2019 Jun; 69(6):2455-2470. PubMed ID: 30715741
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity.
Régnier M; Polizzi A; Smati S; Lukowicz C; Fougerat A; Lippi Y; Fouché E; Lasserre F; Naylies C; Bétoulières C; Barquissau V; Mouisel E; Bertrand-Michel J; Batut A; Saati TA; Canlet C; Tremblay-Franco M; Ellero-Simatos S; Langin D; Postic C; Wahli W; Loiseau N; Guillou H; Montagner A
Sci Rep; 2020 Apr; 10(1):6489. PubMed ID: 32300166
[TBL] [Abstract][Full Text] [Related]
17. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
18. A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH).
Srivastava J; Robertson CL; Ebeid K; Dozmorov M; Rajasekaran D; Mendoza R; Siddiq A; Akiel MA; Jariwala N; Shen XN; Windle JJ; Subler MA; Mukhopadhyay ND; Giashuddin S; Ghosh S; Lai Z; Chen Y; Fisher PB; Salem AK; Sanyal AJ; Sarkar D
Hepatology; 2017 Aug; 66(2):466-480. PubMed ID: 28437865
[TBL] [Abstract][Full Text] [Related]
19. The Transcription Factor IRF6 Co-Represses PPARγ-Mediated Cytoprotection in Ischemic Cerebrovascular Endothelial Cells.
Huang R; Hu Z; Feng Y; Yu L; Li X
Sci Rep; 2017 May; 7(1):2150. PubMed ID: 28526834
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
